- Home
- Family Medicine
- MedX Weekly: Sasanlimab with SOC for Bladder Cancer, New Patient Blood Management Guidelines & More
7mo2 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. Sasanlimab and Standard of Care BCG Improve Event-Free Survival in High-Risk Bladder Cancer Sasanlimab combination therapy significantly improves event-free survival in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who
MedX Weekly: Sasanlimab with SOC for Bladder Cancer, New Patient Blood Management Guidelines & More
7772 Reached3 Comments
Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

Woman presented with Fever of Unknown Origin
7733 Reached93 Comments19 Likes

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Use of Clindamycin for Managing Bacterial Vaginosis
11224 Reached29 Comments8 Likes

Black Lesion in Old Female
1974 Reached5 Comments11 Likes
